Pharmafile Logo
Pharmafocus logo
Advanced Search

GSK

Showing 15 posts of 760 posts found.

paolo_poletti_nucana

NuCana appoints GSK oncology head

December 2, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, Paolo Paoletti, biomed, nucana

Edinburgh-based clinical stage biopharma firm NuCana BioMed has appointed Dr Paolo Paoletti to its board of directors.  Paoletti has been …

Appointment
GSK image

GSK Ebola vaccine ‘promising’ in early trials

November 27, 2014
Research and Development, Sales and Marketing Africa, Ebola, GSK, Takeda, Vaccine, WHO, vaccines

The first trial results for GlaxoSmithKline’s (GSK) Ebola vaccine candidate have shown that the medicine was well-tolerated and produced an …

News
Ebola image

Takeda: we’re working on Ebola too

November 24, 2014
Research and Development, Sales and Marketing Ebola, GSK, Gates, Obama, WHO, brett wells, pharmafile, rajeev, vaccines, venkaya, venkayya

The president of Takeda Vaccines has told Pharmafile that the Japanese firm has identified compounds that could help prevent infection …

News
GSK image

GSK tests mHealth trial solutions

November 19, 2014
Medical Communications, Sales and Marketing Apple, GSK, Medidata, dr Vries, healthpatch, mhealth

GlaxoSmithKline is experimenting with mobile health (mHealth) devices linked to cloud services in clinical trials as part of a bid …

News
GSK image

GSK tops pharma league for access

November 17, 2014
Sales and Marketing Africa, GSK, Novo Nordisk, access, market, vaccines

GlaxoSmithKline is basking in some good news after topping the league table of pharma companies which do the most to …

News
GSK image

NICE backs GSK’s leukaemia drug Arzerra following price cut

November 4, 2014
Sales and Marketing Arzerra, CLL, GSK, NHS, NICE, leukaemia

NICE has recommended that GlaxoSmithKline’s Arzerra be prescribed under the NHS for patients with chronic lymphocytic leukaemia (CLL), after a …

News
Viiv image

GSK mulls $27 billion ViiV sell-off

October 23, 2014
Medical Communications, Sales and Marketing AIDS, Advair, GSK, HIV, Pfizer, Q3, Shionogi, Tivicay, ViiV

After a difficult few years and another poor quarter, GlaxoSmithKline has announced that it is looking to float its fast-growing …

News
Ebola image

GSK: Ebola vaccines will come ‘too late’

October 17, 2014
Manufacturing and Production, Research and Development, Sales and Marketing Ebola, GSK, JK-05, Sihuan, tekmira, vaccines, zmapp

GlaxoSmithKline says its potential Ebola vaccine will come ‘too late’ for the current outbreak despite being fast-tracked. In August the …

News
Novartis image

Novartis says three executives departing firm

October 9, 2014
Medical Communications, Sales and Marketing Andrin Oswald, Brian McNamara, GSK, George Gunn, Novartis, lilly, oncology, vaccines

Swiss pharma giant Novartis has announced three of its executives are to leave the firm following deals with Lilly and …

News
Sir Philip Hampton image

New chairman to take seat at GSK

September 25, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing China, GSK, RBS, gent, philip hampton

The Royal Bank of Scotland’s chairman Sir Philip Hampton has been appointed by GlaxoSmithKline to succeed Sir Christopher Gent in …

News
gsk_china_2_2_0

GSK fined, executives face jail sentence in Chinese bribery case

September 19, 2014
Medical Communications, Research and Development, Sales and Marketing China, GSK, Witty, bribery, sex tape

China has fined Britain’s largest pharma firm GlaxoSmithKline $490 million (£297m) for corruption after a year-long investigation into claims it …

News

GSK melanoma drug sees quick NICE nod

September 18, 2014
Sales and Marketing Cancer, GSK, NICE, Tafinlar, Yervoy, dabrafenib, melanoma, skin cancer

NICE is recommending GlaxoSmithKline’s new melanoma treatment Tafinlar (dabrafenib) after the firm offered a discount for its medicine. In final …

News
BMS image

Bristol-Myers Squibb: following the string of pearls

September 8, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, BMS, GSK, Johanna Mercier, Pfizer, UCB, Yervoy, acquisitions

Bristol-Myers Squibb (BMS) is something of an enigma in the pharma industry. Whilst many of its big pharma peers are …

Feature

China: a dangerous game that pharma must play

September 1, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing China, GSK, chinese, emerging, market access, pharma, susie lunt

Set to be the biggest country for pharma growth in the 21st century, with rising levels of chronic disease, an …

Feature
GSK image

GSK Ebola vaccine fast-tracked into human trials

August 28, 2014
Sales and Marketing Africa, Ebola, GSK, WHO, zmapp

GlaxoSmithKline has announced that its experimental Ebola vaccine is being fast-tracked into human studies to help deal with the worst-ever …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025